Evidence map›Paper›PMID 42035155›Full record

ArticleEnvironmental health : a global access science source2026

Air pollution and mortality in a University of Michigan amyotrophic lateral sclerosis cohort: a survival analysis.

Meredith Pedde, Sara D Adar, Dae-Gyu Jang, Eva L Feldman, Stephen A Goutman

Abstract read
In one paragraph

Article in Environmental health : a global access science source, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meredith PeddeDepartment of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, Michigan, 48109-2029, USA. mpedde@umich.edu.ORCID http://orcid.org/0000-0003-2099-9221
Sara D AdarDepartment of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, Michigan, 48109-2029, USA.ORCID http://orcid.org/0000-0001-8383-485X
Dae-Gyu JangDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID http://orcid.org/0009-0009-7966-1322
Eva L FeldmanDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID http://orcid.org/0000-0002-9162-2694
Stephen A GoutmanDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID http://orcid.org/0000-0001-8780-6637

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)R01AG070883 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI AMY J. KIND · 2021 to 2026
$42.1M
Mapping the ALS Exposome to Gain New Insights into Disease Risk and PathogenesisR01ES030049 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BATTERMAN, STUART A, FELDMAN, EVA LUCILLE · 2020 to 2024
$3.5M
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohortR01NS127188 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BATTERMAN, STUART A, FELDMAN, EVA LUCILLE · 2021 to 2024
$3.4M
Creating a foundation for personalized age- and sex-based immune-targeted therapies from an ALS longitudinal cohort by identifying peripheral and central immune signaturesR01NS120926 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GOUTMAN, STEPHEN, MURDOCK, BENJAMIN JOSEPH · 2021 to 2025
$3.0M
Impact of Geospatial Factors and Environmental Pollutants on Amyotrophic Lateral Sclerosis in the State of MichiganK23ES027221 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GOUTMAN, STEPHEN · 2017 to 2021
$1.0M
ATSDR CDC HHS R01 TS000327ATSDR CDC HHS R01TS000327NCATS NIH HHS UL1 TR002240NIA NIH HHS R01 AG070883NIEHS NIH HHS K23 ES027221NIEHS NIH HHS R01 ES030049NINDS NIH HHS R01 NS120926NINDS NIH HHS R01 NS127188
6 · The paper itself

Abstract

backgroundAmyotrophic lateral sclerosis (ALS) is a rare, fatal, neurodegenerative disease. With limited treatment options, identifying modifiable risk factors that impact ALS survival is an important goal. Air pollution may be one such risk factor, yet the research on this topic is limited.

methodsWe assessed survival for ALS patients at the University of Michigan Pranger ALS Clinic who were recruited to participate in a prospective cohort study between 2009 and 2022. Participants’ personal characteristics were linked with residential air pollutant levels of fine particulate matter mass (PM2.5), nitrogen dioxide (NO2), and ozone (O3), as well as several particle components, including black carbon (BC), nitrate, sulfate, and sea-salt (as a negative control) over follow-up. To assess the role of air pollution on ALS mortality we used time-dependent Cox proportional hazards models with days from diagnosis as the time axis, adjusted for potential confounders and co-pollutants.

resultsAcross the 1,276 total years of person-time during follow-up (2.7 ± 2.5 years per participant) there were 329 deaths. In fully adjusted multi-pollutant models, one interquartile range (IQR) (2.1 µg/m3) higher 1-year average PM2.5 was associated with a 66% (HR 1.66 per IQR; 95% CI 1.03–2.68) increase in the hazard of death. The other pollutants were not associated with death in participants with ALS .

conclusionsThis finding suggests a seven month longer median survival for a 2.1 µg/m3 decrease in 1-year average PM2.5, which is significant given that ALS lacks a cure and that existing treatments only extend survival by a few months.

Indexed as

Air PollutantsAir PollutionAmyotrophic Lateral SclerosisEnvironmental ExposureAgedFemaleHumansMaleMichiganMiddle AgedNitrogen DioxideParticulate MatterProspective StudiesSurvival AnalysisAir PollutantsNitrogen DioxideParticulate MatterAir pollutionALSModifiable risk factorMotor neuron diseaseSurvival

Identifiers

PMID42035155
PMCPMC13251212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.